| 000 | 01504 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514224610.0 | ||
| 264 | 0 | _c20050922 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/keh668 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNissen, M J | |
| 245 | 0 | 0 |
_aRheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cAug 2005 |
||
| 300 |
_a1016-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Infectious _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRheumatic Diseases _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFontanges, E | |
| 700 | 1 | _aAllam, Y | |
| 700 | 1 | _aZoulim, F | |
| 700 | 1 | _aTrépo, C | |
| 700 | 1 | _aMiossec, P | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 44 _gno. 8 _gp. 1016-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/keh668 _zAvailable from publisher's website |
| 999 |
_c15522161 _d15522161 |
||